DDInter981 DDInter1952
Isocarboxazid has the formula 1-benzyl-2-(5-methyl-3-isoxazolylcarbonyl)hydrazine-isocarboxazid. It is a monoamine oxidase inhibitor. It is used in the treatment of major depression, dysthymic disorder, atypical disorder, panic disorder and the phobic disorders. It was first introduced by Roche pharmaceuticals, further developed by Validus pharms Inc and first FDA approved as a prescription drug on July 1st, 1959.
Xylometazoline is an alkylbenzene.
Isocarboxazid {u} (Compound) downregulates {v} (Gene) STUB1
STUB1 {u} (Gene) is downregulated by {v} (Compound) Xylometazoline
Isocarboxazid {u} (Compound) resembles {v} (Compound) Metamfetamine
Metamfetamine {u} (Compound) binds {v} (Gene) ADRA2B
ADRA2B {u} (Gene) is bound by {v} (Compound) Xylometazoline
Isocarboxazid {u} (Compound) downregulates {v} (Gene) STUB1
STUB1 {u} (Gene) is regulated by {v} (Gene) ADRA2A
ADRA2A {u} (Gene) is bound by {v} (Compound) Xylometazoline
Isocarboxazid {u} (Compound) palliates {v} (Disease) panic disorder
panic disorder {u} (Disease) is associated with {v} (Gene) ADRA2A
ADRA2A {u} (Gene) is bound by {v} (Compound) Xylometazoline
Isocarboxazid {u} (Compound) downregulates {v} (Gene) STUB1
STUB1 {u} (Gene) is downregulated by {v} (Compound) Salmeterol
Salmeterol {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Xylometazoline
Isocarboxazid {u} (Compound) causes {v} (Side Effect) Loss of consciousness
Loss of consciousness {u} (Side Effect) is caused by {v} (Compound) Amoxapine
Amoxapine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Xylometazoline
Isocarboxazid {u} (Compound) palliates {v} (Disease) panic disorder
panic disorder {u} (Disease) is palliated by {v} (Compound) Venlafaxine
Venlafaxine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Xylometazoline
Isocarboxazid {u} (Compound) resembles {v} (Compound) Metamfetamine
Metamfetamine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Olodaterol
Olodaterol {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Xylometazoline
Isocarboxazid {u} (Compound) causes {v} (Side Effect) Loss of consciousness
Loss of consciousness {u} (Side Effect) is caused by {v} (Compound) Desvenlafaxine
Desvenlafaxine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Xylometazoline
Isocarboxazid {u} (Compound) resembles {v} (Compound) Metamfetamine
Metamfetamine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Isoprenaline
Isoprenaline {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Xylometazoline
Isocarboxazid (Compound) downregulates STUB1 (Gene) and STUB1 (Gene) is downregulated by Xylometazoline (Compound)
Isocarboxazid (Compound) resembles Metamfetamine (Compound) and Metamfetamine (Compound) binds ADRA2B (Gene) and ADRA2B (Gene) is bound by Xylometazoline (Compound)
Isocarboxazid (Compound) downregulates STUB1 (Gene) and STUB1 (Gene) is regulated by ADRA2A (Gene) and ADRA2A (Gene) is bound by Xylometazoline (Compound)
Isocarboxazid (Compound) palliates panic disorder (Disease) and panic disorder (Disease) is associated with ADRA2A (Gene) and ADRA2A (Gene) is bound by Xylometazoline (Compound)
Isocarboxazid (Compound) downregulates STUB1 (Gene) and STUB1 (Gene) is downregulated by Salmeterol (Compound) and Salmeterol may cause a moderate interaction that could exacerbate diseases when taken with Xylometazoline
Isocarboxazid (Compound) causes Loss of consciousness (Side Effect) and Loss of consciousness (Side Effect) is caused by Amoxapine (Compound) and Amoxapine may cause a moderate interaction that could exacerbate diseases when taken with Xylometazoline
Isocarboxazid (Compound) palliates panic disorder (Disease) and panic disorder (Disease) is palliated by Venlafaxine (Compound) and Venlafaxine may cause a moderate interaction that could exacerbate diseases when taken with Xylometazoline
Isocarboxazid (Compound) resembles Metamfetamine (Compound) and Metamfetamine may cause a moderate interaction that could exacerbate diseases when taken with Olodaterol and Olodaterol may cause a moderate interaction that could exacerbate diseases when taken with Xylometazoline
Isocarboxazid (Compound) causes Loss of consciousness (Side Effect) and Loss of consciousness (Side Effect) is caused by Desvenlafaxine (Compound) and Desvenlafaxine may cause a moderate interaction that could exacerbate diseases when taken with Xylometazoline
Isocarboxazid (Compound) resembles Metamfetamine (Compound) and Metamfetamine may cause a moderate interaction that could exacerbate diseases when taken with Isoprenaline and Isoprenaline may cause a moderate interaction that could exacerbate diseases when taken with Xylometazoline